Nephron mass and cardiovascular and renal disease risks.
about
Hypertension in infancy: diagnosis, management and outcomeOuabain protects against adverse developmental programming of the kidneyBmp7 maintains undifferentiated kidney progenitor population and determines nephron numbers at birthSex-specific effect of antenatal betamethasone exposure on renal oxidative stress induced by angiotensins in adult sheepSerum creatinine levels are significantly influenced by renal size in the normal pediatric population.Clinicopathological assessment of the nephron number.Maternal undernourished fetal kidneys exhibit differential regulation of nephrogenic genes including downregulation of the Notch signaling pathwayDevelopmental cigarette smoke exposure: kidney proteome profile alterations in low birth weight pups.Stage specific requirement of Gfrα1 in the ureteric epithelium during kidney developmentEarlier recognition of nephrotoxicity using novel biomarkers of acute kidney injury.The long-term renal and cardiovascular consequences of prematurity.Factors associated with a vicious cycle involving a low nephron number, hypertension and chronic kidney disease.Kidney volume and ambulatory blood pressure in children.Developmental cigarette smoke exposure II: Kidney proteome profile alterations in 6 month old adult offspring.Urinary neutrophil gelatinase-associated lipocalin at birth predicts early renal function in very low birth weight infants.Long-term pulmonary effects of intrauterine exposure to endotoxin following preterm birth in sheep.Temporal expression of the PGE2 synthetic system in the kidney is associated with the time frame of renal developmental vulnerability to cyclooxygenase-2 inhibition.The microcirculation: a target for developmental priming.COX-2 gene dosage-dependent defects in kidney development.
P2860
Q28303900-58937E88-8FB6-41E0-988A-107C26CE9D38Q30497121-EC6810F7-4D6C-4581-AD59-260017DDD678Q31133744-A554D713-88E4-4887-90D9-F2BC400134E7Q34439799-DE10C468-9FF3-48CC-AD22-710D3F2E2492Q34497170-F077F6AC-B032-4F3F-90A3-268931DA0D26Q35227666-021F1A55-43B7-4356-A3EE-BC717CE65AEAQ35931101-E8D96A07-1863-45E8-881E-948B60D76C2EQ36975901-52B26BCA-F49F-4F59-BD5F-212107390991Q37042855-FD6030DE-E3B6-4B44-A1A5-0FCF88563D59Q37942277-F9C5FAE3-38B5-4A64-977D-348D7FA281F9Q37988805-3E752A0C-D070-499E-94F1-0681663F9224Q38530387-3D8C8422-4300-47B9-B2BD-3FC7615A22AFQ39041140-E7BA7650-9BFC-4B31-A53F-20098644B27AQ41585375-4B55FE73-5AC9-4E62-973F-37A44B52AA7CQ47370600-E66E6327-6BA0-4A48-BFD9-1144F5CF5B3CQ50790211-7A5AAE81-669D-4839-BA79-504BBC8F9657Q51785189-925AD680-310A-4AC7-951E-EA90349ED5F1Q51878877-9B117C4A-3C0A-42F1-BBC1-574D20B322B7Q53625530-6AC80D28-268D-4802-813D-07B307A6EC6B
P2860
Nephron mass and cardiovascular and renal disease risks.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on July 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Nephron mass and cardiovascular and renal disease risks.
@en
Nephron mass and cardiovascular and renal disease risks.
@nl
type
label
Nephron mass and cardiovascular and renal disease risks.
@en
Nephron mass and cardiovascular and renal disease risks.
@nl
prefLabel
Nephron mass and cardiovascular and renal disease risks.
@en
Nephron mass and cardiovascular and renal disease risks.
@nl
P1476
Nephron mass and cardiovascular and renal disease risks.
@en
P2093
Carolyn L Abitbol
Julie R Ingelfinger
P304
P356
10.1016/J.SEMNEPHROL.2009.03.019
P577
2009-07-01T00:00:00Z